Philip E. Lammers

3.8k total citations
40 papers, 743 citations indexed

About

Philip E. Lammers is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Philip E. Lammers has authored 40 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Philip E. Lammers's work include Lung Cancer Treatments and Mutations (11 papers), Cancer Genomics and Diagnostics (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Philip E. Lammers is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Cancer Genomics and Diagnostics (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Philip E. Lammers collaborates with scholars based in United States, Italy and Germany. Philip E. Lammers's co-authors include Ira Jacobs, Giuseppe Curigliano, Carmen Criscitiello, Josiah Ochieng, Gladys N. Nangami, Amos M. Sakwe, Christian Jackisch, Leora Horn, Thomas H. Cartwright and Bradley J. Monk and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Philip E. Lammers

39 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip E. Lammers United States 18 374 198 167 149 129 40 743
Lorrin Yee United States 17 514 1.4× 446 2.3× 217 1.3× 128 0.9× 86 0.7× 37 1.0k
Parvin F. Peddi United States 14 404 1.1× 206 1.0× 53 0.3× 200 1.3× 80 0.6× 30 661
Fumiya Hongo Japan 17 217 0.6× 435 2.2× 96 0.6× 342 2.3× 77 0.6× 108 973
Qijia Xuan China 18 511 1.4× 325 1.6× 223 1.3× 161 1.1× 45 0.3× 30 922
Jingyu Yu United States 15 871 2.3× 286 1.4× 224 1.3× 439 2.9× 177 1.4× 27 1.3k
Ioannis Zerdes Sweden 15 547 1.5× 237 1.2× 260 1.6× 189 1.3× 43 0.3× 46 878
Jin‐Hee Ahn South Korea 15 522 1.4× 97 0.5× 313 1.9× 86 0.6× 144 1.1× 29 718
Michael Xiang United States 16 351 0.9× 475 2.4× 104 0.6× 295 2.0× 51 0.4× 68 1.1k
Toshiaki Saeki Japan 16 441 1.2× 312 1.6× 56 0.3× 180 1.2× 192 1.5× 43 1.0k
Davide Lombardi Italy 17 609 1.6× 210 1.1× 80 0.5× 308 2.1× 66 0.5× 57 1.0k

Countries citing papers authored by Philip E. Lammers

Since Specialization
Citations

This map shows the geographic impact of Philip E. Lammers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip E. Lammers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip E. Lammers more than expected).

Fields of papers citing papers by Philip E. Lammers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip E. Lammers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip E. Lammers. The network helps show where Philip E. Lammers may publish in the future.

Co-authorship network of co-authors of Philip E. Lammers

This figure shows the co-authorship network connecting the top 25 collaborators of Philip E. Lammers. A scholar is included among the top collaborators of Philip E. Lammers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip E. Lammers. Philip E. Lammers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Thomas, Kimberly, et al.. (2021). Increased ease of access to genetic counseling for low-income women with breast cancer using a point of care screening tool. Journal of Community Genetics. 12(1). 129–136. 2 indexed citations
3.
4.
Ray, Meredith, Nicholas R. Faris, Matthew Smeltzer, et al.. (2021). Survival Impact of an Enhanced Multidisciplinary Thoracic Oncology Conference in a Regional Community Health Care System. JTO Clinical and Research Reports. 2(8). 100203–100203. 9 indexed citations
5.
Hoell, Christin, Julia Wynn, Luke V. Rasmussen, et al.. (2020). Participant choices for return of genomic results in the eMERGE Network. Genetics in Medicine. 22(11). 1821–1829. 24 indexed citations
6.
Ochieng, Josiah, Gladys N. Nangami, Amos M. Sakwe, et al.. (2018). Extracellular histones are the ligands for the uptake of exosomes and hydroxyapatite‐nanoparticles by tumor cells via syndecan‐4. FEBS Letters. 592(19). 3274–3285. 27 indexed citations
7.
Marshall, Dana, et al.. (2018). Abstract 5286: Meharry Medical College medical student summer program in integrative science and cancer research. Cancer Research. 78(13_Supplement). 5286–5286. 1 indexed citations
8.
Amara, Suneetha, et al.. (2018). High salt induces P-glycoprotein mediated treatment resistance in breast cancer cells through store operated calcium influx. Oncotarget. 9(38). 25193–25205. 27 indexed citations
9.
10.
Jackisch, Christian, Philip E. Lammers, & Ira Jacobs. (2017). Evolving landscape of human epidermal growth factor receptor 2-positive breast cancer treatment and the future of biosimilars. The Breast. 32. 199–216. 33 indexed citations
11.
Boutaud, Olivier, Taneem Amin, Hyun Seok Hwang, et al.. (2016). Inhibition of the Biosynthesis of Prostaglandin E2 By Low-Dose Aspirin: Implications for Adenocarcinoma Metastasis. Cancer Prevention Research. 9(11). 855–865. 44 indexed citations
12.
Coleman, Morton, Philip E. Lammers, Fabio Ciceri, & Ira Jacobs. (2016). Role of Rituximab and Rituximab Biosimilars in Diffuse Large B-Cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 16(4). 175–181. 20 indexed citations
13.
Araujo, Luiz H., Philip E. Lammers, Rosana Eisenberg, et al.. (2015). Somatic Mutation Spectrum of Non–Small-Cell Lung Cancer in African Americans: A Pooled Analysis. Journal of Thoracic Oncology. 10(10). 1430–1436. 31 indexed citations
14.
Araujo, Luiz H., Cynthia Timmers, Thanemozhi G. Natarajan, et al.. (2014). Genomic Characterization of Non-Small Cell Lung Cancer in African Americans by Targeted Massively Parallel Sequencing. International Journal of Radiation Oncology*Biology*Physics. 90(5). S70–S70. 3 indexed citations
15.
Lammers, Philip E., Christine M. Lovly, & Leora Horn. (2014). A Patient With Metastatic Lung Adenocarcinoma Harboring ConcurrentEGFRL858R,EGFRGermline T790M, andPIK3CAMutations: The Challenge of Interpreting Results of Comprehensive Mutational Testing in Lung Cancer. Journal of the National Comprehensive Cancer Network. 12(1). 6–11. 10 indexed citations
16.
Lammers, Philip E., Yu Shyr, Alan Sandler, et al.. (2014). Phase II Study of Bendamustine in Relapsed Chemotherapy Sensitive or Resistant Small-Cell Lung Cancer. Journal of Thoracic Oncology. 9(4). 559–562. 20 indexed citations
17.
Naughton, Michael, Catherine Van Poznak, Jochen G. Schneider, et al.. (2013). A Randomized Phase II Trial Investigating the Effect of Platelet Function Inhibition on Circulating Tumor Cells in Patients With Metastatic Breast Cancer. Clinical Breast Cancer. 13(6). 409–415. 29 indexed citations
18.
Lammers, Philip E. & Leora Horn. (2013). Targeting Angiogenesis in Advanced Non-Small Cell Lung Cancer. Journal of the National Comprehensive Cancer Network. 11(10). 1235–1247. 13 indexed citations
19.
Kempson, Stephen A., Jeffrey A. Beck, Philip E. Lammers, J. Scott Gens, & Marshall H. Montrose. (2005). Membrane insertion of betaine/GABA transporter during hypertonic stress correlates with nuclear accumulation of TonEBP. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1712(1). 71–80. 11 indexed citations
20.
Lammers, Philip E., Jeffrey A. Beck, Shaoyou Chu, & Stephen A. Kempson. (2005). Hypertonic upregulation of betaine transport in renal cells is blocked by a proteasome inhibitor. Cell Biochemistry and Function. 23(5). 315–324. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lorrin Yee Breakdown of academic impact, for papers by Parvin F. Peddi Breakdown of academic impact, for papers by Fumiya Hongo Breakdown of academic impact, for papers by Qijia Xuan Breakdown of academic impact, for papers by Jingyu Yu Breakdown of academic impact, for papers by Ioannis Zerdes Breakdown of academic impact, for papers by Jin‐Hee Ahn Breakdown of academic impact, for papers by Michael Xiang Breakdown of academic impact, for papers by Toshiaki Saeki Breakdown of academic impact, for papers by Davide Lombardi
Rankless by CCL
2026